Purchase Order HHSN272201700939P

Award Date 8/4/17
Potential Completion Date 8/7/17
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $11,910.00 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) to Bio X Cell, LLC, a for-profit limited liability company, for the provision of bulk antibodies for research purposes. The award supports the NIH's National Institute of Allergy and Infectious Diseases (NIAID), National Cancer Institute (NCI), and Clinical Center in their work on coronavirus testing, COVID-19 research, vaccine development, and studies on infectious diseases. Bio X Cell has...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Bio X Cell, LLC, a for-profit limited liability company. The $3,770.00 firm fixed price purchase order is for the provision of BIO X CELL RAT IGG1 ISOTYPE CONTROL HRPN and M IFN GAMMA XMG1.2 MG antibodies, which support COVID-19 research as well as research on vaccines and infectious diseases. Bio X Cell has previously provided...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $33,000 firm fixed price purchase order to ABI Scientific Inc. to provide cell growth enhancers and mediums. Under the contract, ABI Scientific will deliver ProBooster, CelBooster, and AbBooster products totaling 90 units to support NIAID's structural analysis, immunogen screening, and pre-clinical animal studies for vaccine development targeting HIV-1, SARS-CoV-2, and other viruses. The...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS), to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The $31,202.00 fixed-price level of effort contract is for process development of vaccine candidates, including for SARS-CoV-2. The award has an ultimate completion date of April 15, 2025. ABL has been awarded multiple indefinite...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $49,946.10 firm-fixed-price purchase order contract for antibody expression services to Biointron Biological USA Inc., a small disadvantaged business. The contract, which has no set-aside designation, has an ultimate completion date of July 11, 2025. The award was made on July 12, 2024. NIAID is responsible for conducting and supporting research to understand, treat, and prevent infectious and...
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $16,345.50 purchase order to Biointron Biological USA Inc. for antibody expression services. As a firm fixed price contract, Biointron will provide the requested antibody expression services to NIH/NIAID at Metuchen, New Jersey from September 19, 2023 through December 29, 2023. No subcontractors or set aside designations were indicated. NIAID conducts and...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $97,312.50 firm fixed-price purchase order contract to Nanocellect Biomedical Inc., a for-profit biotechnology company, for a COVID-19 automated cell sorter. The contract was not set aside for any specific business type. Nanocellect Biomedical Inc. specializes in advanced cell analysis and sorting equipment and has established itself as a key supplier to federal agencies, including NIAID, the...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp, a small, Asian-Pacific American-owned biotechnology company based in Rockville, Maryland. The contract, valued at $98,958.95, is for the provision of various research and development services related to genetics, immunology, virology, and infectious diseases, including...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Nexcelom Bioscience LLC, a for-profit limited liability company that manufactures scientific imaging equipment. The $147,500.00 award is for the purchase of a Celigo Imaging Cytometer - 5 Channels, Classic, Collection Application Suite, along with installation and training, to support the Laboratory of Allergic Disease's...
This firm-fixed-price federal purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Biolegend, Inc., a for-profit manufacturer of biomedical products. The $31,957.50 contract supports the supply of various antibodies, reagents, and kits to advance research initiatives across NIAID, with no set-aside designation. Biolegend has a long history of providing specialized products for...

The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a $14,950.00 firm fixed price purchase order to Bio X Cell, LLC, a for-profit limited liability company. The contract is for the delivery of BIO X CELL AB 1000MG and has an ultimate completion date of August 7, 2017. This award supports COVID-19 research as well as research on vaccines and infectious diseases at the NIAID, and Bio X Cell has previously provided similar research materials and services to the NIAID, National Cancer Institute, and NIH Clinical Center under prior contract awards. The contract has no set-aside designation.

Generated 11/24/24, 9:03 AM